Drug
Platinum clinical trials
- studies test it
- 29
- open now
- 15
- in phase 3
- 5
- first study started
- 2004
Keep track of what changes. Save the Platinum studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
29 studies that test it; most in 2023 (5)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 3 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 15
- Phase 3
- 5
- Phase 4
- 3
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 20
Sun Yat-sen University (2) · China Medical University, China (2) · Peking Union Medical College Hospital (2) · Memorial Sloan Kettering Cancer Center (1) · Fudan University (1) · Biotheus Inc. (1) · Bristol-Myers Squibb (1) · Shanghai Gynecologic Oncology Group (1)
Often tested with
Tested in the same studies.
Etoposide (6) · Pemetrexed (5) · Bevacizumab (4) · Gemcitabine (4) · Anlotinib (3) · Osimertinib (2) · Paclitaxel (2) · Tislelizumab (2)
Studies
Open first, then newest update. How each study uses Platinum is read from its arms, and is right about nine times in ten.
Testing it · 29
- A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NECNot yet recruitingPhase 2Tianjin Medical University Cancer Institute and HospitalNCT07510594Written as Benmelstobart+ Anlotinib+ Platinum + Etoposide
- JSKN033 Combination Therapy in Subjects With Advanced Cervical CancerNot yet recruitingPhase 2Jiangsu Alphamab Biopharmaceuticals Co., LtdNCT07497074Written as Platinum
- Effects of Lower Body Positive Pressure Therapy Versus Alpha Lipoic Acid and Omega-3 Fatty Acids on Knee OsteoarthritisNot yet recruitingPhase 3Badr UniversityNCT07399743Written as Alpha-Lipoic Acid (ALA)+PT
- Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line InductionNot yet recruitingPhase 2China Medical University, ChinaNCT07376499Written as Platinum
- Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid TumorsNot yet recruitingPhase 1/2Qilu Pharmaceutical Co., Ltd.NCT07272590Written as platinum, IV infusion
- Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLCRecruitingPhase 1/2Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.NCT07136285Written as platinum (cisplatin or carboplatin)
- HS-10502 Combination Treatment in Patients With Advanced Solid TumorsRecruitingPhase 1Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT06769425Written as HS-10502 + Platinum + Bevacizumab
- Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line InductionNot yet recruitingPhase 4China Medical University, ChinaNCT06951841Written as Platinum
- Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type AdenocarcinomaNot yet recruitingPhase 3Women's Hospital School Of Medicine Zhejiang UniversityNCT06870565Written as paclitaxel and platinum
- First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLCRecruitingPhase 2Xiaorong DongNCT05745350Written as Pembrolizumab, Plinabulin plus Etoposide and Platinum
- DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.RecruitingPhase 4Fondazione Policlinico Universitario Agostino Gemelli IRCCSNCT06820255Written as Platinum + Gemcitabine
- Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 TrialRecruitingPhase 2Shanghai Pulmonary Hospital, Shanghai, ChinaNCT06256237Written as Platinum
- A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.Not yet recruitingPhase 2Peking Union Medical College HospitalNCT06142617Written as Pembrolizumab, pemetrexed, platinum
- Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain MetastaticRecruitingNot applicableHebei Medical University Fourth HospitalNCT06056115Written as Tislelizumab,Platinum
- Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLCNot yet recruitingPhase 2Jiangsu Cancer Institute & HospitalNCT05782426Written as paclitaxel polymeric micelles for injection
- A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung CancersActive, not recruitingPhase 1Memorial Sloan Kettering Cancer CenterNCT03567642Written as Platinum
- Bevacizumab Plus Nab-paclitaxel and Platinum for Immunotherapy-treated Non-squamous Non-small Cell Lung CancerActive, not recruitingNot applicableFudan UniversityNCT05407155Written as bevacizumab plus nab-paclitaxel and platinum
- Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung CancerCompletedPhase 3Sun Yat-sen UniversityNCT01951482Written as Pemetrexed/Platinum
- A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLCActive, not recruitingPhase 2Biotheus Inc.NCT05844150Written as Platinum
- Trial of BMS-986012 in Combination With Platinum and EtoposideCompletedPhase 1Bristol-Myers SquibbNCT02815592Written as Platinum
See all 29 studies that test Platinum →
Given in every arm · 16 — Platinum is usual care beside what is tested
- A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor CancerRecruitingPhase 1Memorial Sloan Kettering Cancer CenterNCT07532902Written as Platinum
- Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033Not yet recruitingPhase 2Shanghai Pulmonary Hospital, Shanghai, ChinaNCT07097948Written as Platinum
- A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid TumorsNot yet recruitingPhase 1Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT06963502Written as platinum (cisplatin or carboplatin)
- Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal CancerNot yet recruitingPhase 2Fujian Cancer HospitalNCT05628610Written as Platinum: cisplatin, carboplatin, naidaplatin and other platinum drugs
- Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast CancerRecruitingPhase 2Fudan UniversityNCT06355037Written as Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1/platinum
- Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.Not yet recruitingPhase 2Obstetrics & Gynecology Hospital of Fudan UniversityNCT06128460Written as Platinum
- Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 TrialRecruitingPhase 3Sun Yat-sen UniversityNCT04502641Written as Platinum
- Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer PatientsRecruitingPhase 3Chinese Academy of Medical SciencesNCT03731442Written as Platinum
- A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsCompletedPhase 1/2TakedaNCT04420884Written as Platinum
- Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung CancerCompletedPhase 2Shanghai Pulmonary Hospital, Shanghai, ChinaNCT06648200Written as Platinum
- JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLCActive, not recruitingPhase 2Shanghai Junshi Bioscience Co., Ltd.NCT06969027Written as Platinum
- Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLCCompletedPhase 3Innovent Biologics (Suzhou) Co. Ltd.NCT03607539Written as Platinum
- Inosine Reverse Chemo Resistance in Triple Negative Breast CancerCompletedPhase 2Fudan UniversityNCT06355024Written as Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1/platinum
- A Study of Apatinib Treatment in for Advanced Ovarian CancerStatus unknownPhase 2The People's Hospital of LeshanNCT03393507Written as Taxus + platinum
- Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard TreatmentStatus unknownPhase 2The First Affiliated Hospital of Anhui Medical UniversityNCT03224221Written as fluorouracil and platinum
- Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast CancerStatus unknownPhase 2Xinjiang Medical UniversityNCT02489409Written as Platinum
As the comparator · 4 — what is tested is compared with Platinum
- SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast CancerActive, not recruitingPhase 2UNICANCERNCT02299999Written as Platinum based chemotherapies
- Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLCStatus unknownPhase 2Tang-Du HospitalNCT04338620Written as albumin-bound paclitaxel and platinum
- Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLCCompletedPhase 2/3Fudan UniversityNCT01769066Written as Pemetrexed/Platinum
- Randomized Gefitinib TrialCompletedPhase 3Fondazione Humanitas per la RicercaNCT00807066Written as Platinum
Codes
What other systems call Platinum · ClinicalTrials.gg INT008048
- MeSH (NLM) D010984PlatinumOne source NLM
- UNII (FDA) 49DFR088MYPLATINUMConfirmed FDA, NLM, Wikidata
- RxNorm 1311280Confirmed FDA, Wikidata
- Wikidata Q126615080PlatinumConfirmed FDA, NLM, Wikidata
- Wikidata Q27882222platinumConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C756PlatinumOne source FDA
- DrugBank DB12257One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D010984 | Platinum | One source NLM |
| UNII (FDA) | 49DFR088MY | PLATINUM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1311280 | — | Confirmed FDA, Wikidata |
| Wikidata | Q126615080 | Platinum | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27882222 | platinum | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C756 | Platinum | One source FDA |
| DrugBank | DB12257 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.